Hybrigenics is a French bio-pharmaceutical company listed in Paris, focusing its internal R&D programs on innovative targets and therapies for the treatment of proliferative diseases.
Year founded1998
Served areaWorldwide
Headquarters9 Avenue du Canal Philippe Lamour, 30660 Gallargues le Montueux – France
264,350,017
IPODec. 17, 2007
Stock exchange(s)Euronext Paris